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Abstract
Bioactive glass nanoparticles (BG-NPs), based on both ternary (SiO2–CaO–P2O5) and binary
(SiO2–CaO) systems, were prepared via an optimized sol–gel method. The pH of preparation
and the effect of heat treatment temperature were evaluated, as well as the effect of suppressing
P in the bioactivity ability of the materials. The morphology and composition of the BG-NPs
were studied using FTIR, XRD and SEM. The bioactive character of these materials was
accessed in vitro by analyzing the ability for apatite formation onto the surface after being
immersed in simulated body fluid (SBF). XRD, EDX and SEM were used to confirm the
bioactivity of the materials. The BG-NP effect on cell metabolic activity was assessed by
seeding L929 cells with their leachables, proving the non-cytotoxicity of the materials. Finally
the most bioactive BG-NPs developed (ternary system prepared at pH 11.5 and treated at
700 ◦C) were successfully combined with chitosan in the production of biomimetic
nanocomposite osteoconductive membranes that could have the potential to be used in guided
tissue regeneration.
1. Introduction
When bioactive glasses were discovered, they radically
changed the biomaterials field. For the first time, a chemical
bond between implants and host tissue was possible, leaving
behind a first generation of bioinert devices. This was the
beginning of a second generation of bioactive materials capable
of inducing a cellular response at their surface. These materials
were able to bond not only to bone, but to soft tissue as well,
avoiding fibrous encapsulation [1, 2]. Moreover, the broad
scope of the possible compositions leads to different chemical
properties and rate of bonding with tissues, allowing more
specific clinical applications [3].
The first bioactive glass developed by Hench in 1971 was
composed of SiO2, CaO, Na2O and P2O5 (Bioglass®) [2]. The
first bioactive glasses were produced by melting the required
materials and casting of the bulk or quenching of powders [2].
In 1991, Li et al produced bioactive glasses by sol–gel
processing [4]. Sol–gel is a wet-chemical processing method
more appropriate to produce these glasses as an alternative to
the traditional melting method, because it allows a wider range
of SiO2 content and higher purity of the obtained products [5].
The SiO2–CaO–P2O5 system is one of the most exten-
sively studied in the field of bioactive sol–gel glasses [6–9].
However, the majority of these bioactive glasses are prepared
by direct heating of the gels, after allowing gelation to occur,
which results in a hard block that must be ground and sieved to
reach particle sizes at the microscale. Microsized particles of
bioactive glasses are commonly used, but there are not many
works exploring the advantages of using nanosized particles.
Nanoparticles have sizes of the order of 10–100 nm
in diameter and, unlike bulk materials, the biological
response of these particles is highly dependent on their
dimensions and specific surface area [10, 11]. Bioactive
glass nanoparticles may have a significant function as well
in the genetic control of the cellular response. Additionally,
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their particular characteristics which have anti-inflammatory
and proangiogenic potential are ideal for applications like
minimally invasive injectable particles for stable growth of soft
tissues [12, 13].
The use of particles within the nanoscale may open
new possibilities in the biomedical area, including in bone
repairing, based on the combination of such materials with
biopolymers, as the increased surface area improves the
mechanical properties of these new biomaterials and provides
more nucleation sites for apatite, increasing their bioactive
potential, making this kind of composite great candidates for
third-generation tissue engineering [14–16, 9, 17–21, 3, 22].
This study aims to investigate the effects of different
compositions (SiO2–CaO–P2O5 and SiO2–CaO) and thermal
treatments on the morphology and in vitro bioactivity of BG-
NPs. As is referred to in the literature, the morphology and
size of the bioactive particles can be controlled by the rate of
the hydrolysis and condensation reactions [10]. The pH was
therefore also chosen in this work as a parameter to study its
influence on the morphology and the size of the bioactive glass
particles.
A sol–gel method was previously combined with
coprecipitation and applied in this work to different
formulation systems in order to obtain nanosized particles [23].
The advantage of combining these materials with biopolymers
is also investigated and a composite of chitosan and the BG-
NPs is developed.
2. Experimental methods
2.1. BG-NP preparation
To prepare the BG-NPs a protocol based on previous works
was followed [24, 25]. The procedure for the ternary BG-NP
preparation, with the composition SiO2:CaO:P2O5 (mol%) =
55:40:5, consisted in sequential reagent dissolutions that
resulted in hydrolysis and polycondensation reactions. The
same procedure with the necessary adaptations was followed
to obtain SiO2:CaO (mol%) = 70:30, in which no P precursor
was used. Tetraethyl orthosilicate (TEOS, 99.90% pure) was
used as the Si precursor, ammonium phosphate dibasic as
the P precursor, calcium nitrate tetrahydrate (99%) as the
Ca precursor, citric acid monohydrate (99–100%) to promote
hydrolysis, ethanol absolute, ammonium hydroxide (maximum
of 33% NH3) as the gellyfying agent and polyethylene glycol
20 000 (PEG) as the surfactant were purchased from Sigma-
Aldrich. In some cases the BG-NPs were sintered at 700 ◦C,
according to the thermogravimetric and differential thermal
analysis (TG/DTA) study of dried gels of a similar system
performed by Ma et al [26].
2.2. Chitosan/BG-NPs composite preparation
The membranes were obtained dissolving chitosan
(0.7 wt/vol%) and BG-NPs (0.3 wt/vol%) in 2 vol% acetic
acid. The control membranes contain 1 wt/vol% of chitosan.
After evaporation for several days, the membranes were
neutralized in NaOH 0.1 M, and left to dry.
2.3. XRD analysis
X-ray diffraction measurements were performed with a Bruker
D8 Discover model operated at 40 kV and 40 mA using Cu Kα
radiation. The detector was scanned over a range of 2θ angles
from 15◦ to 60◦ at a step size of 0.04◦ and dwell time of 1 s per
step.
2.4. FTIR spectroscopy analysis
Fourier-transform infrared (FTIR) spectroscopy analysis was
carried out in an IR Prestige 21 Shimadzu spectrometer. The
samples were prepared by pressing the BG-NPs with KBr
into a small disc. The FTIR spectra were recorded from
400 to 4400 cm−1 with the resolution of 4 cm−1. Before
measurements the powders were dried at 100 ◦C overnight to
remove any adsorbed molecules.
2.5. In vitro bioactivity study
In vitro bioactivity tests were carried out by soaking 10 mg of
bioactive glass in 15 ml of SBF (simulated body fluid) solution
in the case of BG-NPs powders, and 1 cm2 per 50 ml of SBF
in the case of chitosan/BG-NPs composite for zero (control),
one, three, five and seven days at 37 ◦C. Upon removing from
SBF, the samples were rinsed with distilled water and left to
dry. The SBF was prepared by dissolving NaCl, NaHCO3,
KCl, K2HPO4·3H2O, MgCl2·6H2O and Na2SO4 in distilled
water and buffered with Tris buffer and HCl to reach a pH
value of 7.4, following the protocol described by Kokubo and
Takadama [27]. All materials were purchased from Sigma-
Aldrich.
2.6. SEM and EDX sample preparation
To study the surface and the morphology of the samples,
a NanoSEM—FEI Nova 200 (FEG/SEM) scanning electron
microscope was used. A conductive gold coating was applied
to the samples. A Pegasus X4M instrument was used to
perform the EDX experiments at low vacuum and without
coating.
2.7. Cell viability tests
Cell viability and metabolic activity were determined using
the MTS assay. L929 mouse fibroblasts were seeded in
a multi-wall plate and nourished with Dulbecco’s modified
minimum essential medium (D-MEM) supplemented with
10% fetal bovine serum (FBS) and 1% antibiotic. The plates
were incubated at 37 ◦C with 5% CO2. In the meantime,
fluid extracts were obtained by placing in a falcon tube
0.2 g of sterile BG-NPs per ml of culture medium. After
24 h under stirring at 37 ◦C, the media, with different
extracts from each sample, were filtered and applied, as
the nourishment medium, to the plates containing the cells
previously seeded. The cultures were then incubated at 37 ◦C
for one, three and seven days. The culture media was replaced
on the third day. The MTS (3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)
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test was performed to determine the cytotoxicity of the BG-
NPs. In this assay, the tetrazolium compound is reduced
by the viable cell’s mitochondria into a water-soluble brown
formazan product. The relative viability (%) of the cells was
determined by comparing the obtained results with cells grown
without BG-NP extracts that were used as a positive control of
cell viability. Latex was considered to be a negative control
of cellular viability. After each time point (one, three and
seven days of culture), the MTS test was performed to assess
the metabolic activity of the cells in contact with the BG-NP
extracts. For this assay, an MTS solution was prepared by
using a 1:5 ratio of MTS reagent and D-MEM culture medium
(without phenol red or FBS). After removal of the fluid extracts
and washing with PBS, 100 μl of MTS reagent was added
to each sample followed by a 3 h incubation period at 37 ◦C.
Finally, the cell supernatant of each sample was removed to
another plate and their optical density (OD) was read at 490 nm
on a microplate reader (Synergy HT, Bio-Tek Instruments).
The values of optical density are directly proportional to the
quantity of formazan product and thereby to the number of
living cells analyzed. All cytotoxicity tests were conducted by
using five replicates.
3. Results and discussion
BG-NPs were obtained by the sol–gel method. This is a
very straightforward method to produce bioactive glasses;
nevertheless, it still requires some important steps such as the
addition of a basic catalyst to promote precipitation of the
particulate gel and the reduction of the gelation time [28, 29],
as well as a heat treatment to incorporate calcium and remove
organic residues [10]. Therefore, besides the study of the
formulation’s influence, the pH resulting from the addition
of different amounts of NH4OH as the basic catalyst and the
differences between samples heat-treated and non-heat-treated
were also analyzed.
3.1. Chemical composition
3.1.1. X-ray diffraction (XRD). XRD patterns of the
studied samples are shown in figure 1. As is well known,
glass is an amorphous inorganic material with no detectable
diffraction maxima. Therefore, it is expected that the bioactive
glass diffractograms will reflect the amorphous nature of this
material. Indeed, XRD spectra of both the binary and ternary
system prepared at pH 11.5 and after thermal treatment,
respectively figures 1(d) and (h), exhibit a broad dispersive
band, indicating the amorphous nature of the bioactive glass.
Before being submitted to the thermal treatment, the
diffractograms present two parasite lines (19◦ and 24◦)
reported in the literature as being associated with Si [30]. After
the thermal treatment process, the lines disappear.
Hong et al concluded that the crystallinity of bioactive
glass ceramic nanoparticles obtained with the same preparation
conditions could increase with increasing phosphate con-
tent [31]. However, comparing the diffractograms in figure 1 of
binary (with no P) and ternary (with 5% P) samples obtained at
different pH (9 and 11.5) and temperatures (0 and 700 ◦C), one
Figure 1. XRD spectra of raw and thermally treated BG-NPs
produced at different pH and formulations: binary pH 9 (a) 0 ◦C,
(b) 700 ◦C; binary pH 11.5 (c) 0 ◦C, (d) 700 ◦C; ternary pH 9 (e) 0 ◦C,
(f) 700 ◦C; ternary pH 11.5 (g) 0 ◦C, (h) 700 ◦C and hydroxyapatite
peaks are indicated (*).
can conclude that the major differences in crystallinity arise
from the pH of preparation. The spectra do not reflect the
composition of the system in terms of the presence or absence
of P. However, the pH of preparation seems to be the most
important factor setting the amorphous or crystalline character
of the material after the thermal treatment. When working
at pH 9, the sintered sample spectrum from both the binary,
figures 1(a) and (b), and ternary, figures 1(e) and (f), systems
reflect the existence of crystalline phases, as some diffraction
maxima can be observed. Comparing the ternary samples after
thermal treatment (figures 1(f)—pH 9 and (h)—pH 11.5), the
main difference is related to the crystallinity. With respect to
the ternary sample prepared at pH 9, figure 1(f), the thermal
treatment process seems to lead to the hydroxyapatite typical
diffractogram. The main lines are typical phosphate crystal
peaks showing the presence of hydroxyapatite, which exhibits
well-defined diffraction maxima at 2θ = 25.9◦, 29◦, 31.8◦,
32.2◦, 32.9◦, 34◦, 39.8◦, 46.7◦, 49.5◦, 50.5◦ and 53.1◦. The
apatite peaks’ presence can be explained based on two different
reasons. The first one is that, in the aqueous environment
of the sol–gel process, precipitation of hydroxyapatite can
occur from the amorphous structure of silica-based bioactive
glasses [32]. However, it could also be the case that the thermal
treatment temperature was excessively high and therefore
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passing the value of minimum stabilization temperature that
ensures a maximum of bioactivity before the crystallization of
the material. A higher crystallinity has a lower dissolution rate
which has a direct detrimental effect on bioactivity [10]. On
the other hand, the sample prepared at pH 11.5, figure 1(h),
presents an amorphous spectrum after thermal treatment very
similar to the one associated with the commercial Bioglass®,
as only the characteristic amorphous band at low angles is
visible. Crystallization of bioactive glasses decreases the level
of bioactivity and even turns a bioactive glass into a bioinert
material [31]. It appears to be the case of the binary samples
prepared at pH 9 (figures 1(a) and (b)), with a considerable
amount of peaks with very high crystallinity, as the size of the
peaks can be related to their crystallinity. These samples are
the ones exhibiting the lower bioactivity as will be confirmed
further in this study.
In all samples except for the sintered ternary powders
prepared at pH 11.5, figure 1(h), the thermal stabilization leads
to a more crystalline sample, which may happen due to the
small size of the particles, which, having a higher specific
surface area, also have higher driving forces for nucleation
in crystals [10]. Samples of the ternary system prepared at
pH 11.5, figures 1(g) and (h), form a broad band centered at a
2θ value of 30◦ that corresponds to the wollastonite (CaSiO3)
phase. Labbaf et al claim that thermal treatment temperatures
should be the lowest value able to retain the particles in
the amorphous state. As a temperature of 700 ◦C was used,
and the amorphous shape was kept, this seems to be the
ideal stabilization temperature before reaching a wollastonite
crystalline phase that would decrease the bioactive potential
of the BG-NPs. Thermal treatment is always a necessary step
because it is essential to incorporate calcium at approximately
450 ◦C, to remove the organic phase at 500 ◦C and to reduce
silanol groups from the glass surface and nitrate by-products
from the glass network at 600 ◦C [10].
3.1.2. FTIR measurements. The FTIR spectra of the
produced BG-NPs are presented in figure 2. Silicate absorption
bands are observed in all spectra, assigned to the peaks 1085,
800 and 464 cm−1, respectively: asymmetric stretching mode,
symmetric stretching vibration and rocking vibration of Si–O–
Si [26].
In the sintered ternary system sample prepared at pH 9,
figure 2(f), the heating treatment at 700 ◦C is shown by two
narrow peaks at 580 and 600 cm−1, indicating a P–O bending
vibration due to the presence of a crystalline calcium phosphate
(apatite-like) phase [26]. These twin bands merge into a weak
band in the case of amorphous glass, figures 2(e), (g) and (h).
This is in accordance with the XRD data. Moreover, the P-
related peaks do not appear in the binary spectra, figures 2(a)–
(d), since they do not include P in their formulation. In
the case of ternary system samples, figures 2(e)–(h), peaks
at 1045 and 1090 cm−1 are also assigned to the P–O bond
although masked by the broad silicate band [31]. At 950 cm−1
one can confirm the Ca presence due to the peak related to
Si–O–Ca bonds containing non-bridging oxygen [26]. The
1630 cm−1 is assigned to the OH group due to residual H2O
absorbed in the BG-NP [33]. Bands related to the presence
Figure 2. Infrared spectra of raw and thermally treated BG-NPs:
binary pH 9 (a) 0 ◦C, (b) 700 ◦C; binary pH 11.5 (c) 0 ◦C, (d) 700 ◦C;
ternary pH 9 (e) 0 ◦C, (f) 700 ◦C and ternary pH 11.5 (g) 0 ◦C,
(h) 700 ◦C.
of the calcium precursor Ca(NO3)2, 1400–1300 cm−1 (N=O
bend) and 1600–1500 cm−1 (N=O stretch) disappear after
the thermal treatment, confirming the decomposition of the
nitrate Ca(NO3)2 at 700 ◦C, especially the vibrations of ionic
(NO3)− at 1380 cm−1 [33]. These bands are more evident
in the binary pH 9–0 ◦C, figure 2(a) and tend to attenuate
after thermal treatment. Also in figure 2(a), the 1630 cm−1
stretching vibration of the H–O bond, related to water is more
evident. The 1340 cm−1 sharp peak could also be due to the
presence of water as it is assigned to OH free groups. The
1460 cm−1 could be assigned to a carbonate absorption band,
due to the carbonate existing in the lattice of the binary pH 9
BG-NPs, as a result of CO2 dissolution from the atmosphere
during the sol–gel procedure [34]. After thermal treatment this
band disappears.
3.1.3. Energy dispersive x-ray (EDX) analysis. Through
energy dispersive x-ray (EDX) analysis, it was possible to
quantify the final ratios of the binary and ternary compositions
in atomic percentage (at.%). The results are presented in
table 1. The measured values present deviations regarding
the initial formulations. As can be observed in the table, the
particles produced at pH 9 have the right original proportions
of Si and Ca in the binary case, but in the ternary system only
Si is at the original percentage and P is three times higher,
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Table 1. EDX quantification (at.%).
Binary Ternary
pH 9 pH 11.5 pH 9 pH 11.5
at.% 0 ◦C 700 ◦C 0 ◦C 700 ◦C 0 ◦C 700 ◦C 0 ◦C 700 ◦C
Si 70.24 69.15 82.00 81.53 52.63 55.30 33.46 35.31
P 0 0 0 0 14.62 15.01 20.40 21.87
Ca 29.76 30.85 18 18.47 32.75 29.69 46.14 42.81
and consequently Ca is 15% below the original percentage.
At pH 11.5 Si is above the initial value in the binary system
(and Ca below). On the other hand, in the ternary system, Si
is almost 20% below the original set value and Ca remains in
the right proportion, P being four times higher. The reason
for these differences may be the removal of free calcium ions
during the washing step. Indeed, in the sol stage, almost
100% of Ca dissolves in the pore liquor as calcium nitrate,
and it will only deposit in the drying step. Therefore, the final
composition of bioactive glass can be changed if the pore liquor
is washed before drying, removing the calcium that was not
incorporated in the silica or phosphoric gel network [10, 34].
This fact would explain the variation in values obtained, as
the experimental procedure followed in this work includes a
washing step, necessary to remove the ammonia from the gel.
3.2. Surface analysis
Surface analysis was performed by scanning electron
microscopy (SEM) observation. The samples were previously
coated with a thin gold layer. The differences in the BG-
NPs both in size and morphology were analyzed between the
different batches of BG-NPs produced. At pH 9, figures 3(a),
(b) and (e), (f), the size of the particles is more heterogeneous,
especially in the ternary case, figures 3(e) and (f), where
the sizes could vary in the range 50–200 nm. The particles
produced at pH 11.5, figures 3(c), (d) and (g), (h), have sizes
below 40 nm.
Regarding the effect of calcination in the morphologies
of the binary and ternary systems, at pH 9 particles appear to
be melted and more aggregated and at pH 11.5, besides the
aggregation, there is also a decrease in the particles size. This
consequence is not evident in the ternary particles produced
under the same conditions. It is known that temperatures
higher than 700 ◦C, in the ternary system, have the effect of
melting and sintering the particles in large aggregates [23]. A
shorter temperature of calcination is thought more suitable to
apply in binary systems, in order to avoid the fusion of the
particles and their densification due to the sintering effect.
In all cases the particles are round shaped. Labbaf et al
claim that the spherical shape is in part due to the use of
ammonium hydroxide as catalyst, although the morphology
and size can be as well controlled by the rate of the hydrolysis
and condensation reactions. Even though it is know that, when
using a base catalyst to control the condensation reaction the
particles do not assemble, some agglomeration is observed.
However, the catalyst chosen prevents them fusing together
during thermal treatment [10].
3.3. Cytotoxicity tests of the BG-NPs
The BG-NP effect on cell metabolic activity was assessed by
seeding L929 cells with their leachables. Figure 4 shows the
cell’s viability evaluated by carrying out the MTS test. A
slight decline in the cellular metabolic activity was verified
from the first to the third day in all samples, the decrease
being more relevant in sample (a). The mentioned decrease
was followed by a viability increase from day three to day
seven. These results suggest that the cell’s metabolism is
being influenced by the ions present in the leachables, as
sample (a) showed the presence of more chemical species in
FTIR analysis (see figure 2) and, as a consequence, it has the
most evident decrease in the third day viability. Nevertheless,
the interactions between the cells and the BG-NP leachables
do not affect significantly their viability, as it increases again
towards the seventh day of culturing.
The cell’s behavior throughout the study time proves the
non-toxicity of the materials produced at different pH and
also before and after thermal treatment. Therefore, high
biocompatibility of the materials is ensured in all of the studied
conditions.
3.4. In vitro bioactivity test of the BG-NPs
It is commonly accepted that the bioactivity of glasses relies
on their ability to induce hydroxyapatite formation in a
physiological environment, such as simulated body fluid (SBF)
that reproduces the human plasma by having similar pH and
ionic composition. In this environment, the bioactive glasses
will release ions and form silanol groups on its surface that
will act as a nucleating agent for a hydroxyapatite layer [35].
Being an interface-driven phenomenon, bioactivity will depend
on parameters such as surface charge, composition, structure
and morphology [36]. In fact, these parameters will influence
the dissolution rate of the materials, whose ideal ionic
concentrations will define the ability to stimulate cellular
proliferation and differentiation [2].
3.4.1. X-ray diffraction (XRD). Figure 5 shows the XRD
spectra of the BG-NPs in all of the studied conditions after
soaking in SBF for seven days. In the nonsintered samples
of the binary systems, both pH 9 and 11.5, figures 5(a)
and (c), just one to three of the major diffraction peaks in
the spectra can be interpreted as hydroxyapatite, as a result
of being soaked in SBF after seven days. In contrast, the
sintered binary samples, figures 5(b) and (d), especially the
one prepared at pH 11.5, figure 5(d), have several peaks
related to hydroxyapatite regarding day seven of SBF soaking.
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Figure 3. SEM of raw and thermally treated BG-NPs: binary pH 9 (a) 0 ◦C, (b) 700 ◦C; binary pH 11.5 (c) 0 ◦C, (d) 700 ◦C; ternary pH 9
(e) 0 ◦C, (f) 700 ◦C and ternary pH 11.5 (g) 0 ◦C, (h) 700 ◦C.
In the case of the ternary system without thermal treatment,
figures 5(e) and (g), the particles after seven days present
an apatitic layer at their surface, with several peaks of the
spectrum matching the ones of hydroxyapatite. It is possible to
conclude that, in each system (binary or ternary), at pH 11.5,
figures 5(e)–(h), there are more peaks related to hydroxyapatite
than in the samples produced at pH 9, figures 5(a)–(d).
Regarding the temperature, the heat treatment at 700 ◦C
is conducive to better bioactivity than the non-heat-treated
samples, as the diffraction angles of the peaks after soaking
in SBF match the reference x-ray spectra of hydroxyapatite.
Considering the formulation of the BG-NPs, the ternary system
exhibits a layer of pure hydroxyapatite after seven days of
immersion, when treated at 700 ◦C, at both pHs, figures 5(f)
and (h). One can conclude that the ternary formulation has
better bioactivity results than the binary one, and that thermal
treatment has an important role in promoting the mineralization
ability, regardless of the pH of preparation in this study.
3.4.2. Scanning electron microscopy (SEM). Bioactiv-
ity can be confirmed by observing the development of a
6
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Figure 4. Cytotoxicity test results of raw and thermally treated
BG-NPs over three time points (one, three and seven days): binary
pH 9 (a) 0 ◦C, (b) 700 ◦C; binary pH 11.5 (c) 0 ◦C, (d) 700 ◦C; ternary
pH 9 (e) 0 ◦C, (f) 700 ◦C; ternary pH 11.5 (g) 0 ◦C, (h) 700 ◦C and all
data were expressed as mean ± standard deviation for n = 5.
needle-like apatite layer, forming cauliflower-like clusters
on the surface of the particles, namely hydroxyapatite
(Ca10(PO4)6−x(HPO4)x (OH)2−x ), the main mineral con-
stituent of bone [37].
Observing the images in figure 6, obtained in the SEM
study of the bioactivity of BG-NP powders, one can conclude
that the amount of apatitic crystals at the surface of the samples
increases when the pH is 11.5 instead of 9, and when the
formulation is of a ternary system instead of binary. Indeed,
after seven days of soaking the samples in SBF, it is possible to
observe that the condition with the richer apatitic film is the one
corresponding to the ternary system produced at pH 11.5 both
at 0 ◦C and sintered at 700 ◦C, indicating the best bioactivity in
a qualitative evaluation, figures 6(g) and (h).
The XRD data previously presented support these
conclusions and confirm that the calcified film is related to
hydroxyapatite.
3.4.3. Energy dispersive x-ray analysis (EDX). The results
obtained by SEM were also confirmed by EDX analysis that
allowed the following of the elemental evolution throughout
the time period of study. After soaking in SBF, the expected
behavior of a bioactive material containing Si and Ca (as
in the case of BG-NPs) is the rising of Si accompanied by
the decrease of Ca in the first stage, due to the exchange of
the last elements with H+ and H3O+ from the environment.
After this first step, disruption of the glass network occurs
by hydrolysis and as Si–O–Si bridges break, during which
soluble silica is lost to the solution in the form of Si(OH)4
leading to the formation of silanol groups (Si–OH) at the
BG-NP/solution interface. The OH− groups from silanol
will attract Ca2+ and PO3−4 from the surrounding media and
precipitation occurs. An amorphous calcium phosphate layer
begins to grow on the surface of the sample, and the Ca
and P values increase. In contrast, Si content decreases
Figure 5. XRD spectra of raw and thermally treated BG-NPs
produced at different pH and formulations after seven days of
immersion in SBF: binary pH 9 (a) 0 ◦C, (b) 700 ◦C; binary pH 11.5
(c) 0 ◦C, (d) 700 ◦C; ternary pH 9 (e) 0 ◦C, (f) 700 ◦C; ternary pH 11.5
(g) 0 ◦C, (h) 700 ◦C and hydroxyapatite peaks are indicated (*).
proportionally. The incorporation of OH− and CO2−3 anions
from the solution leads to the final step of mineralization which
is the formation of a crystalline hydroxyapatite layer [38].
In fact, in all systems as the study proceeds, the Si content
decreases and the Ca and P increase. The P is taken out from
the SBF in the case of the binary systems, see figures 7(a)
and (c). This strengthens the indication of the development
of apatite material onto the BG-NP surfaces.
This behavior varies in time according to the bioactive
potential of each sample. In the case of the binary and ternary
systems prepared at pH 9, figures 7(a) and (b), respectively,
the effect of the ion exchange is more significant after the fifth
day of the study, when Si begins to decrease and the Ca and P
values become higher.
In the binary system produced at pH 11.5, figure 7(c), the
apatite begins to develop earlier, after three days of immersion
in SBF. In the case of the ternary system (SiO2–CaO–P2O5)
produced at the same pH, the bioactivity character just needs
one day to express itself, figure 7(d). This last system is then
the most bioactive one.
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Figure 6. SEM images of the BG-NPS after seven days in SBF, revealing cauliflower-like apatite clusters on their surface: binary pH 9
(a) 0 ◦C, (b) 700 ◦C; ternary pH 9 (c) 0 ◦C, (d) 700 ◦C; binary pH 11.5 (e) 0 ◦C, (f) 700 ◦C and ternary pH 11.5 (g) 0 ◦C, (h) 700 ◦C.
Regarding the influence of the BG-NP formulation over
the bioactive ability of these materials, some facts have to
be considered. First, the ability to bond with bone has been
shown to depend largely on the silica (SiO2) content. As the
silica content of the glass increases, the dissolution rate of the
apatite layer becomes slow and the bone-bonding ability of
the materials decreases. A glass with a content of more than
60 wt% silica has a dramatic decrease in its bioactivity [38].
Moreover, the BG-NPs with a higher percentage of Ca are
expected to be more prone to dissolution than the ones with
higher amounts of Si in aqueous environments, since calcium
disrupts the silica network, reducing its network connectivity
(mean number of bridging –Si–O–Si– bonds per silicon atom)
and therefore its stability in solution [10, 39]. Both these facts
could justify the reason why samples from binary systems have
an inferior bioactivity over the ternary ones.
One can conclude that, at the lower pH (9), the obtained
particles are more crystalline which was previously referred to
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Figure 7. EDX study of the bioactivity of the BG-NPs prepared in different conditions at zero, one, three, five and seven days. (a) Binary
pH 9 at 0 and 700 ◦C, (b) ternary pH 9 at 0 and 700 ◦C, (c) binary pH 11.5 at 0 and 700 ◦C and (d) ternary pH 11.5 at 0 and 700 ◦C.
as a drawback in setting the bioactive potential, as it lowers the
dissolution rate to ineffective values. This fact would explain
why the ternary system at pH 11.5 is more bioactive than at
pH 9.
In this study, thermal treatment did not have an influence
on setting the bioactive potential of the BG-NPs. The
differences obtained in the atomic percentages throughout the
days of the study were not significant when the samples had
been sintered, regardless of the formulation of the particles,
although thermal treatment is important to retain the Ca in
the glass network, which is a crucial element for a successful
mineralization.
3.5. Chitosan/BG-NP composite development
Composites found in nature contain an inorganic phase, with
at least one nanometric dimension embedded in an organic
matrix, usually assembled in a complex and hierarchical
structure [40].
Biomimetic osteoconductive nanocomposites may be
obtained by combining bioactive glass/ceramics with a
polymeric matrix [22]. In order to mimic this natural structure,
the most bioactive powders (ternary, pH 11.5, 700 ◦C) were
applied in the development of chitosan membranes containing
BG-NPs dispersed in the polymer. The membranes were
obtained by solvent casting of a solution containing chitosan
(0.7 wt/vol%) and BG-NPs (0.3 wt/vol%).
Chitosan is an excellent biocompatible polymer, although,
by itself, it is not capable of reacting within the physiological
fluids in order to develop apatite crystals and bond to the
bone, figure 8(a). In this study, BG-NPs were applied in
the formation of a composite formed by the polymer and the
glass powders in order to produce a bioactive composite that
allies the remarkable mechanical and processability properties
of chitosan to the mineralization induction ability of BG-
NPs. The nanosize of the particles allows a large dispersion
in the polymer as can be observed in figure 8(b), showing a
uniform membrane surface. After seven days of immersion
in SBF, a dense apatite layer is formed at the surface of the
composite (figure 8(c)). The thickness of the apatitic film can
be observed because the polymeric membrane shrinks upon
drying and the apatite layer breaks (figure 8(d)). This profile
view allows us to estimate the reaction layer thickness as 2 μm
approximately, having an average thickness of the membrane
of 47 μm. In contrast, the pure chitosan membrane does not
present any bioactive character as, after seven days immersion
in SBF, no apatite layer was formed at its surface, proving
that this ability is caused by the BG-NPs. It was proved
then that one can successfully ally the mineralization induction
ability of the BG-NPs with the mechanical advantages of
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Figure 8. SEM images of the (a) pure chitosan membrane after seven days in SBF; (b) composite of 0.7 wt/vol% chitosan and 0.3 wt/vol%
BG-NPS (control = zero days in SBF); (c) composite of 0.7 wt/vol% chitosan and 0.3 wt/vol% BG-NPS after seven days in SBF and
(d) composite of 0.7 wt% chitosan and 0.3 wt% BG-NPS after seven days in SBF at a higher magnification.
the chitosan biopolymer, producing a nanocomposite with
potential applications in bone tissue engineering or in guided
tissue regeneration.
4. Conclusions
In this work, new bioactive glass nanoparticles based on the
SiO2–CaO–P2O5 and SiO2–CaO systems were prepared using
a sol–gel method. Round shaped particles with sizes below 50
nm were achieved within the samples produced at pH 11.5.
The sol–gel BG-NPs obtained in this work, when
immersed in SBF, proved the ability to induce mineralization,
having the desired characteristics of biomaterials used in bone
tissue engineering, i.e. bone bonding and biodegradability.
These two properties are highly desirable at, respectively, early
and late stages of post-implantation.
The best bioactivity results are from by the samples
prepared as a ternary system (SiO2–CaO–P2O5). With the
obtained data, one can conclude that the thermal treatment
at 700 ◦C improves the bioactivity of the BG-NPs produced,
being more effective when the nanoparticles are prepared at
pH 11.5.
Nanocomposites resulting from the combination of these
materials with chitosan exhibited bioactive character and may
be potentially used in a series of orthopedic applications,
including in membranes for tissue guided regeneration.
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